Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04129138 · ClinicalTrials.gov registry record

Patient and Caregiver Attitudes and Beliefs Regarding Prescription of Intranasal Naloxone Spray for Opioid Overdose

A clinical trial of Caregiver and Patient, sponsored by M.D. Anderson Cancer Center.

Active
Registry status
182
Enrollment target
1
Study location

NCT04129138 is a study of Caregiver and Patient that is active but no longer recruiting, run by M.D. Anderson Cancer Center. The registered enrollment target is 182 participants, below the 1,248-participant average among 20 other Caregiver trials with a reported enrollment target (85% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04129138, a study of Caregiver and Patient, is active but no longer recruiting, sponsored by M.D. Anderson Cancer Center.

ACTIVE NOT RECRUITING
Registry status
182 participants
Enrollment target
1
Study location

Study Summary

This trial studies the attitudes and beliefs of high risk patients and caregivers regarding the prescription of intranasal naloxone spray for opioid overdose. Knowledge regarding high risk patients' and caregivers' beliefs and attitudes regarding co-prescription of naloxone spray with opioids may help to identify barriers to prescribing and helping tailor the education to better meet the needs of patients and caregivers.

Conditions Studied

Interventions

  • OTHER Survey Administration

Study Locations (1)

Texas

  • M D Anderson Cancer Center - Houston

Trial Details

FieldValue
Enrollment Target 182 participants
Start Date 2020-07-18
Est. Completion 2026-06-30

Sponsor

M.D. Anderson Cancer Center

2,692 total trials

What the Registry Record Tells You About NCT04129138

The ClinicalTrials.gov registry entry for NCT04129138 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 182 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,248-participant average among 20 other Caregiver trials with a reported enrollment target (85% lower). The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Caregiver appearing as the primary indexed condition, and to 1 intervention - of which Survey Administration is the first listed.

NCT04129138 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT04129138 about?

NCT04129138 is a clinical study titled "Patient and Caregiver Attitudes and Beliefs Regarding Prescription of Intranasal Naloxone Spray for Opioid Overdose". This trial studies the attitudes and beliefs of high risk patients and caregivers regarding the prescription of intranasal naloxone spray for opioid overdose. Knowledge regarding high risk patients' and caregivers' beliefs and attitudes regarding co-prescription of naloxone spray with opioids may he...

What is the current status of trial NCT04129138?

This trial is currently active not recruiting. The enrollment target is 182 participants. The study started on 2020-07-18. Estimated completion is 2026-06-30.

What conditions does trial NCT04129138 study?

This clinical trial studies the following conditions: Caregiver, Patient.

What interventions are being tested in trial NCT04129138?

The interventions under investigation include: Survey Administration (OTHER).

Who is sponsoring clinical trial NCT04129138?

This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04129138 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Caregiver

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.